|
1
|
Licitra L, Bernier J, Cvitkovic E, et al:
Cancer of the nasopharynx. Crit Rev Oncol Hematol. 45:199–213.
2003. View Article : Google Scholar
|
|
2
|
Titcomb CP Jr: High incidence of
nasopharyngeal carcinoma in Asia. J Insur Med. 33:235–238.
2001.PubMed/NCBI
|
|
3
|
Chen MK, Chen TH, Liu JP, Chang CC and
Chie WC: Better prediction of prognosis for patients with
nasopharyngeal carcinoma using primary tumor volume. Cancer.
100:2160–2166. 2004.PubMed/NCBI
|
|
4
|
Leung SF, Zee B, Ma BB, et al: Plasma
Epstein-Barr viral deoxyribonucleic acid quantitation complements
tumor-node-metastasis staging prognostication in nasopharyngeal
carcinoma. J Clin Oncol. 24:5414–5418. 2006. View Article : Google Scholar
|
|
5
|
Sham JS and Choy D: Prognostic factors of
nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol.
63:51–58. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee AW, Poon YF, Foo W, et al:
Retrospective analysis of 5037 patients with nasopharyngeal
carcinoma treated during 1976–1985: overall survival and patterns
of failure. Int J Radiat Oncol Biol Phys. 23:261–270.
1992.PubMed/NCBI
|
|
7
|
Li ZQ, Xia YF, Liu Q, et al:
Radiotherapy-related typing in 842 patients in canton with
nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys.
66:1011–1016. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bolanos-Garcia VM: Aurora kinases. Int J
Biochem Cell Biol. 37:1572–1577. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Andrews PD, Knatko E, Moore WJ and Swedlow
JR: Mitotic mechanics: the auroras come into view. Curr Opin Cell
Biol. 15:672–683. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sen S, Zhou H and White RA: A putative
serine/threonine kinase encoding gene BTAK on chromosome 20q13 is
amplified and overexpressed in human breast cancer cell lines.
Oncogene. 14:2195–2200. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bischoff JR, Anderson L, Zhu Y, et al: A
homologue of Drosophila aurora kinase is oncogenic and
amplified in human colorectal cancers. EMBO J. 17:3052–3065.
1998.PubMed/NCBI
|
|
12
|
Zhou H, Kuang J, Zhong L, et al: Tumour
amplified kinase STK15/BTAK induces centrosome amplification,
aneuploidy and transformation. Nat Genet. 20:189–193. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giet R, Petretti C and Prigent C: Aurora
kinases, aneuploidy and cancer, a coincidence or a real link?
Trends Cell Biol. 15:241–250. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogawa E, Takenaka K, Katakura H, et al:
Perimembrane Aurora-A expression is a significant prognostic factor
in correlation with proliferative activity in non-small-cell lung
cancer (NSCLC). Ann Surg Oncol. 15:547–554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lentini L, Amato A, Schillaci T and Di
Leonardo A: Simultaneous Aurora-A/STK15 overexpression and
centrosome amplification induce chromosomal instability in tumour
cells with a MIN phenotype. BMC Cancer. 7:2122007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guan Z, Wang XR, Zhu XF, et al: Aurora-A,
a negative prognostic marker, increases migration and decreases
radiosensitivity in cancer cells. Cancer Res. 67:10436–10444. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Landen CN Jr, Lin YG, Immaneni A, et al:
Overexpression of the centrosomal protein Aurora-A kinase is
associated with poor prognosis in epithelial ovarian cancer
patients. Clin Cancer Res. 13:4098–4104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee CC, Ho HC, Lee MS, et al: Primary
tumor volume of nasopharyngeal carcinoma: significance for
survival. Auris Nasus Larynx. 35:376–380. 2008.PubMed/NCBI
|
|
19
|
Jeng YM, Peng SY, Lin CY and Hsu HC:
Overexpression and amplification of Aurora-A in hepatocellular
carcinoma. Clin Cancer Res. 10:2065–2071. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia LP, Zhou FF, Yang MT and Liu Q: Roles
of Aurora-A in tumorigenesis and prognosis of breast cancer. Ai
Zheng. 28:668–672. 2009.PubMed/NCBI
|
|
21
|
Zou LJ, Li GQ, Gong LL, et al: Expression
of aurora-A kinase in human lung cancer cell lines PG, A549, and
NCI-H460. Ai Zheng. 24:792–795. 2005.PubMed/NCBI
|
|
22
|
Li D, Zhu J, Firozi PF, et al:
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human
pancreatic cancer. Clin Cancer Res. 9:991–997. 2003.PubMed/NCBI
|
|
23
|
Klein A, Reichardt W, Jung V, Zang KD,
Meese E and Urbschat S: Overexpression and amplification of STK15
in human gliomas. Int J Oncol. 25:1789–1794. 2004.PubMed/NCBI
|
|
24
|
Gritsko TM, Coppola D, Paciga JE, et al:
Activation and overexpression of centrosome kinase BTAK/Aurora-A in
human ovarian cancer. Clin Cancer Res. 9:1420–1426. 2003.PubMed/NCBI
|
|
25
|
Royce ME, Xia W, Sahin AA, et al:
STK15/Aurora-A expression in primary breast tumors is correlated
with nuclear grade but not with prognosis. Cancer. 100:12–19. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kurrey NK, Jalgaonkar SP, Joglekar AV, et
al: Snail and slug mediate radioresistance and chemoresistance by
antagonizing p53-mediated apoptosis and acquiring a stem-like
phenotype in ovarian cancer cells. Stem Cells. 27:2059–2068. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsuji T, Ibaragi S and Hu GF:
Epithelial-mesenchymal transition and cell cooperativity in
metastasis. Cancer Res. 69:7135–7139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wan XB, Long ZJ, Yan M, et al: Inhibition
of Aurora-A suppresses epithelial-mesenchymal transition and
invasion by downregulating MAPK in nasopharyngeal carcinoma cells.
Carcinogenesis. 29:1930–1937. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong MH, Mai HQ, Min HQ, Ma J, Zhang EP
and Cui NJ: A comparison of the Chinese 1992 and fifth-edition
International Union Against Cancer staging systems for staging
nasopharyngeal carcinoma. Cancer. 89:242–247. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soumaoro LT, Uetake H, Higuchi T, Takagi
Y, Enomoto M and Sugihara K: Cyclooxygenase-2 expression: a
significant prognostic indicator for patients with colorectal
cancer. Clin Cancer Res. 10:8465–8471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Masunaga R, Kohno H, Dhar DK, et al:
Cyclooxygenase-2 expression correlates with tumor
neovascularization and prognosis in human colorectal carcinoma
patients. Clin Cancer Res. 6:4064–4068. 2000.PubMed/NCBI
|
|
32
|
Tong T, Zhong Y, Kong J, et al:
Overexpression of Aurora-A contributes to malignant development of
human esophageal squamous cell carcinoma. Clin Cancer Res.
10:7304–7310. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hoque A, Carter J, Xia W, et al: Loss of
aurora A/STK15/BTAK overexpression correlates with transition of in
situ to invasive ductal carcinoma of the breast. Cancer Epidemiol
Biomarkers Prev. 12:1518–1522. 2003.PubMed/NCBI
|
|
34
|
Burum-Auensen E, De Angelis PM, Schjolberg
AR, Kravik KL, Aure M and Clausen OP: Subcellular localization of
the spindle proteins Aurora A, Mad2, and BUBR1 assessed by
immunohistochemistry. J Histochem Cytochem. 55:477–486. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanaka E, Hashimoto Y, Ito T, et al: The
clinical significance of Aurora-A/STK15/BTAK expression in human
esophageal squamous cell carcinoma. Clin Cancer Res. 11:1827–1834.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wan XB, Fan XJ, Chen MY, et al: Inhibition
of Aurora-A results in increased cell death in 3-dimensional
culture microenvironment, reduced migration and is associated with
enhanced radiosensitivity in human nasopharyngeal carcinoma. Cancer
Biol Ther. 8:1500–1506. 2009. View Article : Google Scholar
|
|
37
|
Farias TP, Dias FL, Lima RA, et al:
Prognostic factors and outcome for nasopharyngeal carcinoma. Arch
Otolaryngol Head Neck Surg. 129:794–799. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chu ST, Wu PH, Chou P and Lee CC: Primary
tumor volume of nasopharyngeal carcinoma: prognostic significance
for recurrence and survival rate. Eur Arch Otorhinolaryngol.
265(Suppl 1): S115–S120. 2008.PubMed/NCBI
|
|
39
|
Miyoshi Y, Iwao K, Egawa C and Noguchi S:
Association of centrosomal kinase STK15/BTAK mRNA expression with
chromosomal instability in human breast cancers. Int J Cancer.
92:370–373. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sen S, Zhou H, Zhang RD, et al:
Amplification/overexpression of a mitotic kinase gene in human
bladder cancer. J Natl Cancer Inst. 94:1320–1329. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Neben K, Korshunov A, Benner A, et al:
Microarray-based screening for molecular markers in medulloblastoma
revealed STK15 as independent predictor for survival. Cancer Res.
64:3103–3111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Reiter R, Gais P, Jutting U, et al: Aurora
kinase A messenger RNA overexpression is correlated with tumor
progression and shortened survival in head and neck squamous cell
carcinoma. Clin Cancer Res. 12:5136–5141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Marumoto T, Zhang D and Saya H: Aurora-A -
a guardian of poles. Nat Rev Cancer. 5:42–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Agnese V, Bazan V, Fiorentino FP, et al:
The role of Aurora-A inhibitors in cancer therapy. Ann Oncol.
18(Suppl 6): vi47–vi52. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu Q, Kaneko S, Yang L, et al: Aurora-A
abrogation of p53 DNA binding and transactivation activity by
phosphorylation of serine 215. J Biol Chem. 279:52175–52182. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Katayama H, Sasai K, Kawai H, et al:
Phosphorylation by aurora kinase A induces Mdm2-mediated
destabilization and inhibition of p53. Nat Genet. 36:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang H, Ou CC, Feldman RI, Nicosia SV,
Kruk PA and Cheng JQ: Aurora-A kinase regulates telomerase activity
through c-Myc in human ovarian and breast epithelial cells. Cancer
Res. 64:463–467. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tanaka E, Hashimoto Y, Ito T, et al: The
suppression of aurora-A/STK15/BTAK expression enhances
chemosensitivity to docetaxel in human esophageal squamous cell
carcinoma. Clin Cancer Res. 13:1331–1340. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qian CN, Guo X, Cao B, et al: Met protein
expression level correlates with survival in patients with
late-stage nasopharyngeal carcinoma. Cancer Res. 62:589–596.
2002.PubMed/NCBI
|
|
50
|
Chen CL and Ou DL: Expression of
syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with
advanced stage and poor prognosis. Hum Pathol. 37:1279–1285. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lai JP, Tong CL, Hong C, et al:
Association between high initial tissue levels of cyclin d1 and
recurrence of nasopharyngeal carcinoma. Laryngoscope. 112:402–408.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lin JC, Wang WY, Chen KY, et al:
Quantification of plasma Epstein-Barr virus DNA in patients with
advanced nasopharyngeal carcinoma. N Engl J Med. 350:2461–2470.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Song LB, Zeng MS, Liao WT, et al: Bmi-1 is
a novel molecular marker of nasopharyngeal carcinoma progression
and immortalizes primary human nasopharyngeal epithelial cells.
Cancer Res. 66:6225–6232. 2006. View Article : Google Scholar
|
|
54
|
Cheng AL, Huang WG, Chen ZC, et al:
Identificating cathepsin D as a biomarker for differentiation and
prognosis of nasopharyngeal carcinoma by laser capture
microdissection and proteomic analysis. J Proteome Res.
7:2415–2426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liao WT, Song LB, Zhang HZ, et al:
Centromere protein H is a novel prognostic marker for
nasopharyngeal carcinoma progression and overall patient survival.
Clin Cancer Res. 13:508–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chang KP, Hsu CL, Chang YL, et al:
Complementary serum test of antibodies to Epstein-Barr virus
nuclear antigen-1 and early antigen: a possible alternative for
primary screening of nasopharyngeal carcinoma. Oral Oncol.
44:784–792. 2008. View Article : Google Scholar
|
|
57
|
Chin D, Boyle GM, Porceddu S, Theile DR,
Parsons PG and Coman WB: Head and neck cancer: past, present and
future. Expert Rev Anticancer Ther. 6:1111–1118. 2006. View Article : Google Scholar : PubMed/NCBI
|
